1Q25 revenues of $682.3 million 1Q25 net income of $75.5 million, adjusted EBITDA(1) of $129.8 million 1Q25 diluted GAAP EPS of $0.82, non-GAAP(1) EPS of $0.91 Acquisition of Kinectrics Inc. on track to close in mid-2025 Land purchase in Oak Ridge, Tennessee to ultimately support the U.S. Department of Energy's National Nuclear Security Administration Domestic Uranium Enrichment Centrifuge Experiment Reaffirms 2025 non-GAAP EPS(1) guidance of $3.40-$3.55

LYNCHBURG, Va., May 05, 2025--(BUSINESS WIRE)--BWX Technologies, Inc. (NYSE: BWXT) ("BWXT", "we", "us" or the "Company") reported first quarter 2025 results. A reconciliation of non-GAAP results is detailed in Exhibit 1.

"We had a solid start to 2025 with financial results that were ahead of expectations, driven by an increased pace of work and good operational performance," said Rex D. Geveden, president and chief executive officer. "We had another quarter of strong Commercial backlog growth and see robust opportunities for growth in our Government markets, highlighted by our recent land purchase to support the National Nuclear Security Administration's domestic uranium enrichment program."

"BWXT’s foundation is providing our customers with mission critical nuclear products and solutions, and I am proud of the diversified and resilient portfolio we have built over our nearly ten years as a standalone company," continued Geveden. "Our vertically integrated nuclear capabilities, unique infrastructure, and highly-skilled workforce enable our customers to put their trust in BWXT to support their most important programs through all economic cycles in the global security, clean energy, and nuclear medicine markets."

"Our robust backlog, strong demand in our end-markets, operational excellence programs, and recent acquisitions, including the pending Kinectrics acquisition, provide confidence in our near and medium-term outlook," said Geveden. "As such, we are reaffirming our 2025 financial guidance."

Financial Results Summary

Three Months Ended March 31,  2025    2024   $ Change  % Change (Unaudited)

(In millions, except per share amounts) Revenues  Government Operations  $ 555.3   $ 487.1   $ 68.2   14% Commercial Operations  $ 128.3   $ 117.0   $ 11.3   10% Consolidated  $ 682.3   $ 604.0   $ 78.3   13% Operating Income  Government Operations  $ 97.7   $ 85.7   $ 12.1   14% Commercial Operations  $ 6.5   $ 8.6   $ (2.1 )  (25)% Unallocated Corporate (Expense)  $ (7.6 )  $ (1.3 )  $ (6.3 )  NM Consolidated  $ 96.6   $ 93.0   $ 3.7   4% Consolidated non-GAAP(1)  $ 105.8   $ 94.6   $ 11.2   12% EPS (Diluted)  GAAP  $ 0.82   $ 0.75   $ 0.07   9% Non-GAAP(1)  $ 0.91   $ 0.76   $ 0.15   20% Net Income  GAAP  $ 75.5   $ 68.5   $ 7.0   10% Non-GAAP(1)  $ 84.0   $ 69.8   $ 14.2   20% Adjusted EBITDA(1)  Government Operations  $ 116.9   $ 99.9   $ 17.0   17% Commercial Operations  $ 14.0   $ 13.9   $ 0.1   —% Unallocated Corporate  $ (1.1 )  $ 1.3   $ (2.5 )  NM Consolidated  $ 129.8   $ 115.2   $ 14.6   13% Cash Flows  Operating Cash Flow(2)  $ 50.7   $ 33.0   $ 17.6   53% Capital Expenditures(2)  $ 33.4   $ 30.4   $ 2.9   10% Free Cash Flow(1)  $ 17.3   $ 2.6   $ 14.7   565% Dividends Paid(2)  $ 23.7   $ 22.4   $ 1.3   6% NM = Not Meaningful (1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors. (2) Items named in the Financial Results Summary differ from names in BWXT Financial Statement. Operating Cash Flow = Net Cash Provided by Operating Activities; Capital Expenditures = Purchases of Property, Plant and Equipment; Dividends Paid = Dividends Paid to Common Shareholders

Revenues

First quarter revenue increased in both operating segments. The Government Operations increase was driven by higher naval nuclear component production, special materials processing, and contribution from the acquisition of A.O.T., partially offset by lower microreactor volumes. The Commercial Operations increase was driven by higher revenue associated with commercial nuclear components and fuel handling, as well as higher medical sales, partially offset by lower field services activity due to timing on life-extension and outage projects.

Story Continues

Operating Income and Adjusted EBITDA(1)

First quarter GAAP operating income increased as an increase in Government Operations was partially offset by lower Commercial Operations and higher corporate expense, as well as restructuring and transformation, and acquisition related costs. First quarter non-GAAP(1) operating income increased as increases in both operating segments were partially offset by higher corporate expense. The Government Operations increase was driven by higher revenue and solid operational performance. The Commercial Operations increase was driven by higher revenue and partially offset by revenue mix, material procurement costs, and growth investment.

First quarter adjusted EBITDA(1) increased for the reasons noted above.

EPS

First quarter GAAP EPS increased as higher operating income, a lower tax rate, and slightly lower interest expense, were partially offset by lower other income. Non-GAAP EPS(1) increased driven by the items noted above.

Cash Flows

First quarter operating cash flow increased driven by higher net income, working capital management, and timing of awards. Capital expenditures increased slightly due to timing of select growth investments, including the previously announced expansion of the Cambridge manufacturing plant that supports the commercial nuclear market.

Dividend

BWXT paid $23.7 million, or $0.25 per common share, to shareholders in the first quarter of 2025. On May 1, 2025, the BWXT Board of Directors declared a quarterly cash dividend of $0.25 per common share payable on June 5, 2025, to shareholders of record on May 19, 2025.

2025 Guidance

BWXT reaffirmed all components of its 2025 financial guidance.

(In millions, except per share amounts)  Year Ended  Year Ending  December 31, 2024  December 31, 2025  Results  Current Guidance  Revenue  $2,704  ~$3,000  Adjusted EBITDA(1)  $499  ~$550 - $570  Non-GAAP(1) Earnings Per Share  $3.33  ~$3.40 - $3.55  Free Cash Flow(1)  $255  $265 - $285

Additional information can be found in the first quarter 2025 earnings call presentation on the BWXT investor relations website at www.bwxt.com/investors. The Company does not provide GAAP guidance because it is unable to reliably forecast most of the items that are excluded from GAAP to calculate non-GAAP results. These items could cause GAAP results to differ materially from non-GAAP results.

Conference Call to Discuss First Quarter 2025 Results

Date: Monday, May 5, 2025, at 5:00 p.m. EDT Live Webcast: Investor Relations section of website at www.bwxt.com

Full Earnings Release Available on BWXT Website

A full version of this earnings release is available on our Investor Relations website at http://investors.bwxt.com/1Q2025-release.

BWXT may use its website (www.bwxt.com) as a channel of distribution of material Company information. Financial and other important information regarding BWXT is routinely accessible through and posted on our website. In addition, you may elect to automatically receive e-mail alerts and other information about BWXT by enrolling through the "Email Alerts" section of our website at http://investors.bwxt.com.

Non-GAAP Measures

BWXT uses and makes reference to adjusted EBITDA, non-GAAP EPS, free cash flow and free cash flow conversion, which are not recognized measures under GAAP. BWXT is providing these non-GAAP measures to supplement the results provided in accordance with GAAP and it should not be considered superior to, or as a substitute for, the comparable GAAP measures. BWXT believes the non-GAAP measures provide meaningful insight and transparency into the Company’s operational performance and provides these measures to investors to help facilitate comparisons of operating results with prior periods and to assist them in understanding BWXT's ongoing operations. Definitions for the non-GAAP measures are provided below and reconciliations are detailed in Exhibit 1, except that reconciliations of forward-looking GAAP measures are not provided because the company is unable to reliably forecast most of the items that are excluded from GAAP to calculate non-GAAP results. Other companies may define these measures differently or may utilize different non-GAAP measures, thus impacting comparability.

Non-GAAP Earnings Per Share (EPS) is calculated using GAAP EPS less the non-operational tax effected per share impact of pension & OPEB mark-to-market gains or losses and other one-time items, such as restructuring, transformation, acquisition-related costs, and acquisition-related amortization.

Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) is calculated using non-GAAP net income, plus provision for income taxes, less other – net, less interest income, plus interest expense, plus depreciation and amortization.

Adjusted pre-tax income is non-GAAP income before provision for income taxes.

Free Cash Flow (FCF) is calculated using net income to derive net cash provided by (used in) operating activities less purchases of property, plant and equipment.

Free Cash Flow conversion is free cash flow divided by net income.

Non-GAAP Adjustments

Our GAAP financial results detailed in Exhibit 1 have been adjusted for the following items:

Restructuring and Transformation Costs: Restructuring and transformation costs include restructuring charges as well as costs associated with our efforts to optimize underlying business processes through investments in information technology, process improvements and the implementation of strategic actions and initiatives which we deem to be incremental and non-recurring in nature.

Acquisition-related Costs: Acquisition-related costs relate to third-party professional service costs and one-time incremental costs associated with due diligence activities and efforts to integrate the acquired business with our legacy operations.

Forward-Looking Statements

BWXT cautions that this release contains forward-looking statements, including, without limitation, statements relating to backlog, to the extent they may be viewed as an indicator of future revenues; our plans and expectations for each of our reportable segments, including growth opportunities and the expectations, timing and revenue of our strategic initiatives, such as medical radioisotopes, SMR components and recent acquisitions; disruptions to our supply chain and/or operations, changes in government regulations and other factors; and our expectations and guidance for 2025 and beyond. These forward-looking statements are based on management’s current expectations and involve a number of risks and uncertainties, including, among other things, our ability to execute contracts in backlog; federal budget uncertainty, the risk of future budget cuts, the impact of continuing resolution funding mechanisms and the debt ceiling, the potential for government shutdowns and changing funding and acquisition priorities; the demand for and competitiveness of nuclear products and services; capital priorities of power generating utilities and other customers; the timing of technology development, regulatory approvals and automation of production; the receipt and/or timing of government approvals; the potential recurrence of subsequent waves or strains of COVID-19 or similar diseases; labor market challenges, including employee retention and recruitment; adverse changes in the industries in which we operate; and delays, changes or termination of contracts in backlog. If one or more of these risks or other risks materialize, actual results may vary materially from those expressed. For a more complete discussion of these and other risk factors, see BWXT’s filings with the Securities and Exchange Commission, including our annual report on Form 10-K for the year ended December 31, 2024 and subsequent Form 10-Q filings. BWXT cautions not to place undue reliance on these forward-looking statements, which speak only as of the date of this release, and undertakes no obligation to update or revise any forward-looking statement, except to the extent required by applicable law.

About BWXT

At BWX Technologies, Inc. (NYSE: BWXT), we are People Strong, Innovation Driven. A U.S.-based company, BWXT is a Fortune 1000 and Defense News Top 100 manufacturing and engineering innovator that provides safe and effective nuclear solutions for global security, clean energy, environmental restoration, nuclear medicine and space exploration. With approximately 8,700 employees, BWXT has 15 major operating sites in the U.S., Canada and the U.K. In addition, BWXT joint ventures provide management and operations at a dozen U.S. Department of Energy and NASA facilities. For more information, visit www.bwxt.com. Follow us on LinkedIn, X, Facebook and Instagram.

(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.

EXHIBIT 1

BWX TECHNOLOGIES, INC. RECONCILIATION OF NON-GAAP OPERATING INCOME AND EARNINGS PER SHARE(1)(2)(3) (In millions, except per share amounts)  Three Months Ended March 31, 2025  GAAP  Restructuring
&
Transformation
Costs  Acquisition-
related Costs  Acquisition
related
Amortization  Non-GAAP  Government Operations Operating Income $ 97.7   $ 0.2   $ 0.9   $ 1.8   $ 100.6  Commercial Operations Operating Income $ 6.5   $ 1.9   $ 1.6   $ —   $ 9.9  Unallocated Corporate Operating Income $ (7.6 )  $ 2.7   $ 2.0   $ —   $ (2.9 ) Operating Income $ 96.6   $ 4.8   $ 4.4   $ 1.8   $ 107.6  Other Income (Expense)  (4.8 )   —    —    —    (4.8 ) Income Before Provision for Income Taxes  91.8    4.8    4.4    1.8    102.8  Provision for Income Taxes  (16.3 )   (1.1 )   (1.0 )   (0.4 )   (18.8 ) Net Income  75.5    3.7    3.4    1.4    84.0  Net Income Attributable to Noncontrolling Interest  (0.1 )   —    —    —    (0.1 ) Net Income Attributable to BWXT $ 75.5   $ 3.7   $ 3.4   $ 1.4   $ 84.0   Diluted Shares Outstanding  91.9          91.9  Diluted Earnings per Common Share $ 0.82   $ 0.04   $ 0.04   $ 0.02   $ 0.91  Effective Tax Rate  17.7 %         18.3 %

Three Months Ended March 31, 2024 GAAP  Restructuring
Costs  Acquisition-
related Costs  Non-GAAP  Government Operations Operating Income $ 85.7   $ —   $ —   $ 85.7  Commercial Operations Operating Income $ 8.6   $ 0.9   $ —   $ 9.4  Unallocated Corporate Operating Income $ (1.3 )  $ 0.7   $ 0.1   $ (0.5 ) Operating Income $ 93.0   $ 1.6   $ 0.1   $ 94.6  Other Income (Expense)  (4.6 )   —    —    (4.6 ) Income Before Provision for Income Taxes  88.4    1.6    0.1    90.0  Provision for Income Taxes  (19.8 )   (0.4 )   (0.0 )   (20.2 ) Net Income  68.5    1.2    —    69.8  Net Income Attributable to Noncontrolling Interest  (0.1 )   —    —    (0.1 ) Net Income Attributable to BWXT $ 68.5   $ 1.2   $ —   $ 69.7   Diluted Shares Outstanding  91.9        91.9  Diluted Earnings per Common Share $ 0.75   $ 0.01   $ 0.00   $ 0.76  Effective Tax Rate  22.5 %       22.5 %

EXHIBIT 1 (continued)

RECONCILIATION OF CONSOLIDATED ADJUSTED EBITDA(1)(2)(3)

(In millions)  Three Months Ended March 31, 2025 GAAP  Restructuring
&
Transformation
Costs   Acquisition-
related Costs   Acquisition-
related
Amortization  Non-GAAP  Net Income $ 75.5   $ 3.7   $ 3.4   $ 1.4   $ 84.0  Provision for Income Taxes  16.3    1.1    1.0    0.4    18.8  Other – net  (2.5 )   —    —      (2.5 ) Interest Expense  8.0    —    —      8.0  Interest Income  (0.7 )   —    —      (0.7 ) Depreciation & Amortization  23.9    —    —    (1.8 )   22.1  Adjusted EBITDA $ 120.5   $ 4.8   $ 4.4   $ —   $ 129.8

Three Months Ended March 31, 2024 GAAP  Restructuring
Costs   Acquisition-
related
Costs   Non-GAAP  Net Income $ 68.5   $ 1.2   $ —   $ 69.8  Provision for Income Taxes  19.8    0.4    0.0    20.2  Other – net  (4.2 )   —    —    (4.2 ) Interest Expense  9.6    —    —    9.6  Interest Income  (0.8 )   —    —    (0.8 ) Depreciation & Amortization  20.6    —    —    20.6  Adjusted EBITDA $ 113.5   $ 1.6   $ 0.1   $ 115.2

RECONCILIATION OF REPORTING SEGMENT ADJUSTED EBITDA(1)(2)(3)(4) (In millions)  Three Months Ended March 31, 2025 Operating
Income
(GAAP)  Non-GAAP
Adjustments(3,4)  Acquisition-
related
Amortization  Depreciation &
Amortization(4)   Adjusted
EBITDA  Government Operations $ 97.7   $ 1.1  $ 1.8  $ 16.3   $ 116.9  Commercial Operations $ 6.5   $ 3.5  $ —  $ 4.0   $ 14.0  Unallocated Corporate $ (7.6 )  $ 4.6  $ —  $ 1.8   $ (1.1 )

Three Months Ended March 31, 2024

... Operating Income
(GAAP)  Non-GAAP
Adjustments(3)  Depreciation &
Amortization   Adjusted
EBITDA  Government Operations $ 85.7   $ —  $ 14.2   $ 99.9 Commercial Operations $ 8.6   $ 0.9  $ 4.4   $ 13.9 Unallocated Corporate $ (7.6 )  $ 0.8  $ 1.9   $ 1.3

EXHIBIT 1 (continued)

RECONCILIATION OF CONSOLIDATED FREE CASH FLOW(1)(2)(3)

(In millions)  Three Months Ended March 31, 2025  Net Cash Provided By Operating Activities $ 50.7  Purchases of Property, Plant and Equipment  (33.4 ) Free Cash Flow $ 17.3

Three Months Ended March 31, 2024  Net Cash Provided By Operating Activities $ 33.0  Purchases of Property, Plant and Equipment  (30.4 ) Free Cash Flow $ 2.6

(1)  Tables may not foot due to rounding. (2)  BWXT is providing non-GAAP information regarding certain of its historical results and guidance on future earnings per share to supplement the results provided in accordance with GAAP and it should not be considered superior to, or as a substitute for, the comparable GAAP measures. BWXT believes the non-GAAP measures provide meaningful insight and transparency into the Company’s operational performance and provides these measures to investors to help facilitate comparisons of operating results with prior periods and to assist them in understanding BWXT's ongoing operations. (3)  For Non-GAAP adjustment details, see reconciliation of non-GAAP operating income and earnings per share. (4)  Excludes acquisition-related amortization

BWX TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME  Three Months Ended March 31, 2025  2024 (Unaudited)

(In thousands, except share and per share amounts) Revenues  $ 682,258   $ 603,966  Costs and Expenses:  Cost of operations   517,065    455,357  Research and development costs   2,013    1,490  Gains on asset disposals and impairments, net   (4,431 )   —  Selling, general and administrative expenses   87,569    67,361  Total Costs and Expenses   602,216    524,208  Equity in Income of Investees   16,588    13,203  Operating Income   96,630    92,961  Other Income (Expense):  Interest income   722    846  Interest expense   (7,994 )   (9,595 ) Other – net   2,459    4,165  Total Other Income (Expense)   (4,813 )   (4,584 ) Income before Provision for Income Taxes   91,817    88,377  Provision for Income Taxes   16,291    19,843  Net Income  $ 75,526   $ 68,534  Net Income Attributable to Noncontrolling Interest   (64 )   (66 ) Net Income Attributable to BWX Technologies, Inc.  $ 75,462   $ 68,468  Earnings per Common Share:  Basic:  Net Income Attributable to BWX Technologies, Inc.  $ 0.82   $ 0.75  Diluted:  Net Income Attributable to BWX Technologies, Inc.  $ 0.82   $ 0.75  Shares used in the computation of earnings per share:  Basic   91,594,084    91,555,384  Diluted   91,873,702    91,860,923

BWX TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS  Three Months Ended March 31, 2025  2024 (Unaudited) (In thousands) CASH FLOWS FROM OPERATING ACTIVITIES:  Net Income  $ 75,526   $ 68,534  Adjustments to reconcile net income to net cash provided by operating activities:  Depreciation and amortization   23,912    20,552  Income of investees, net of dividends   1,781    (2,400 ) Gains on asset disposals and impairments - net   (4,431 )   —  Recognition of losses for pension and postretirement plans   797    831  Stock-based compensation expense   5,047    4,297  Other, net   (1,075 )   129  Changes in assets and liabilities, net of effects from acquisitions:  Accounts receivable   19,440    (15,493 ) Accounts payable   5,340    32,832  Retainages   (11,743 )   (26,325 ) Contracts in progress and advance billings on contracts   (26,236 )   (17,174 ) Income taxes   6,427    17,820  Accrued and other current liabilities   9,387    (2,025 ) Pension liabilities, accrued postretirement benefit obligations and employee benefits   (38,808 )   (27,687 ) Other, net   (14,714 )   (20,865 ) NET CASH PROVIDED BY OPERATING ACTIVITIES   50,650    33,026  CASH FLOWS FROM INVESTING ACTIVITIES:  Purchases of property, plant and equipment   (33,369 )   (30,422 ) Acquisition of business   (103,345 )   —  Sales and maturities of securities   1,859    —  Investments, net of return of capital, in equity method investees   (26,400 )   —  Other, net   4,905    99  NET CASH USED IN INVESTING ACTIVITIES   (156,350 )   (30,323 ) CASH FLOWS FROM FINANCING ACTIVITIES:  Borrowings of long-term debt   204,500    120,700  Repayments of long-term debt   (62,625 )   (102,263 ) Repurchases of common stock   (30,000 )   (20,000 ) Dividends paid to common shareholders   (23,660 )   (22,396 ) Cash paid for shares withheld to satisfy employee taxes   (12,883 )   (6,907 ) Settlements of forward contracts, net   8,438    (1,337 ) Other, net   1,021    47  NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES   84,791    (32,156 ) EFFECTS OF EXCHANGE RATE CHANGES ON CASH   2,294    (171 ) TOTAL DECREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS   (18,615 )   (29,624 ) CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD   80,571    81,615  CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS AT END OF PERIOD  $ 61,956   $ 51,991  SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:  Cash paid during the period for:  Interest  $ 5,331   $ 15,461  Income taxes (net of refunds)  $ 10,049   $ 2,161  SCHEDULE OF NON-CASH INVESTING ACTIVITY:  Accrued capital expenditures included in accounts payable  $ 10,469   $ 6,612

BWX TECHNOLOGIES, INC. CONDENSED CONSOLIDATED BALANCE SHEETS  ASSETS  March 31, 
2025  December 31, 
2024 (Unaudited)

(In thousands) Current Assets:  Cash and cash equivalents  $ 55,435  $ 74,109 Restricted cash and cash equivalents   2,813   2,785 Accounts receivable – trade, net   89,142   99,112 Accounts receivable – other   43,256   53,199 Retainages   45,410   33,667 Contracts in progress   639,654   577,745 Inventories   49,648   40,288 Other current assets   50,427   49,092 Total Current Assets   975,785   929,997 Property, Plant and Equipment, Net   1,298,059   1,278,161 Investments   8,509   10,609 Goodwill   349,329   287,362 Deferred Income Taxes   4,730   6,569 Investments in Unconsolidated Affiliates   124,022   99,403 Intangible Assets   187,520   165,325 Other Assets   106,054   92,498 TOTAL ASSETS  $ 3,054,008  $ 2,869,924

BWX TECHNOLOGIES, INC. CONDENSED CONSOLIDATED BALANCE SHEETS  LIABILITIES AND STOCKHOLDERS' EQUITY  March 31, 
2025  December 31, 
2024 (Unaudited)

(In thousands, except share

and per share amounts) Current Liabilities:  Current portion of long-term debt  $ 12,500   $ 12,500  Accounts payable   161,625    158,077  Accrued employee benefits   43,473    77,234  Accrued liabilities – other   72,252    65,100  Advance billings on contracts   194,095    161,290  Total Current Liabilities   483,945    474,201  Long-Term Debt   1,185,356    1,042,970  Accumulated Postretirement Benefit Obligation   16,432    16,515  Environmental Liabilities   96,124    94,225  Pension Liability   78,666    82,602  Other Liabilities   93,450    79,007  Commitments and Contingencies  Stockholders' Equity:  Common stock, par value $0.01 per share, authorized 325,000,000 shares; issued 128,644,088 and 128,320,295 shares at March 31, 2025 and December 31, 2024, respectively   1,286    1,283  Preferred stock, par value $0.01 per share, authorized 75,000,000 shares; No shares issued   —    —  Capital in excess of par value   234,321    228,889  Retained earnings   2,339,531    2,287,151  Treasury stock at cost, 37,283,582 and 36,869,498 shares at March 31, 2025 and December 31, 2024, respectively   (1,431,532 )   (1,388,432 ) Accumulated other comprehensive income (loss)   (43,314 )   (48,211 ) Stockholders' Equity – BWX Technologies, Inc.   1,100,292    1,080,680  Noncontrolling interest   (257 )   (276 ) Total Stockholders' Equity   1,100,035    1,080,404  TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY  $ 3,054,008   $ 2,869,924

BWX TECHNOLOGIES, INC.

BUSINESS SEGMENT INFORMATION  Three Months Ended March 31, 2025    2024  (Unaudited)

(In thousands) REVENUES:  Government Operations  $ 555,286   $ 487,121  Commercial Operations   128,310    117,038  Eliminations   (1,338 )   (193 ) TOTAL  $ 682,258   $ 603,966   SEGMENT INCOME:  Government Operations  $ 97,746   $ 85,686  Commercial Operations   6,466    8,591  SUBTOTAL  $ 104,212   $ 94,277  Unallocated Corporate   (7,582 )   (1,316 ) TOTAL  $ 96,630   $ 92,961   DEPRECIATION AND AMORTIZATION:  Government Operations  $ 18,096   $ 14,234  Commercial Operations   4,019    4,444  Corporate   1,797    1,874  TOTAL  $ 23,912   $ 20,552   CAPITAL EXPENDITURES:  Government Operations  $ 18,500   $ 16,383  Commercial Operations   13,209    13,344  Corporate   1,660    695  TOTAL  $ 33,369   $ 30,422   BACKLOG:  Government Operations  $ 3,583,690   $ 2,908,986  Commercial Operations   1,294,990    726,523  TOTAL  $ 4,878,680   $ 3,635,509   BOOKINGS:  Government Operations  $ 226,397   $ 179,413  Commercial Operations   493,420    62,414  TOTAL  $ 719,817   $ 241,827

View source version on businesswire.com: https://www.businesswire.com/news/home/20250505887007/en/

Contacts

Investor Contact: 
Chase Jacobson
Vice President, Investor Relations
980-365-4300
[email protected]

Media Contact: 
John Dobken
Senior Manager, Media & Public Relations
202-428-6913
[email protected]

View Comments